PERKINELMER INC (PKI) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:PKI • US7140461093

115.24 USD
-1.06 (-0.91%)
At close: May 15, 2023
115.24 USD
0 (0%)
After Hours: 5/15/2023, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, PKI scores 5 out of 10 in our fundamental rating. PKI was compared to 57 industry peers in the Life Sciences Tools & Services industry. PKI scores excellent on profitability, but there are some minor concerns on its financial health. PKI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PKI had positive earnings in the past year.
  • In the past year PKI had a positive cash flow from operations.
PKI Yearly Net Income VS EBIT VS OCF VS FCFPKI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.28%, PKI is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
  • With a decent Return On Equity value of 10.11%, PKI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • PKI's Return On Invested Capital of 6.49% is fine compared to the rest of the industry. PKI outperforms 73.02% of its industry peers.
  • PKI had an Average Return On Invested Capital over the past 3 years of 52.37%. This is significantly above the industry average of 13.80%.
  • The last Return On Invested Capital (6.49%) for PKI is well below the 3 year average (52.37%), which needs to be investigated, but indicates that PKI had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROIC 6.49%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
PKI Yearly ROA, ROE, ROICPKI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.32%, PKI belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
  • PKI's Profit Margin has improved in the last couple of years.
  • PKI has a better Operating Margin (23.43%) than 88.89% of its industry peers.
  • PKI's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 58.39%, PKI is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PKI has grown nicely.
Industry RankSector Rank
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
PKI Yearly Profit, Operating, Gross MarginsPKI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • PKI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • PKI has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for PKI has been reduced compared to a year ago.
PKI Yearly Shares OutstandingPKI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
PKI Yearly Total Debt VS Total AssetsPKI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.51 indicates that PKI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PKI has a Altman-Z score (2.51) which is comparable to the rest of the industry.
  • PKI has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as PKI would need 7.40 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 7.40, PKI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • PKI has a Debt/Equity ratio of 0.53. This is a neutral value indicating PKI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of PKI (0.53) is worse than 68.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Altman-Z 2.51
ROIC/WACC0.65
WACC10.02%
PKI Yearly LT Debt VS Equity VS FCFPKI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.3 Liquidity

  • PKI has a Current Ratio of 2.13. This indicates that PKI is financially healthy and has no problem in meeting its short term obligations.
  • PKI has a worse Current ratio (2.13) than 68.25% of its industry peers.
  • A Quick Ratio of 1.87 indicates that PKI should not have too much problems paying its short term obligations.
  • PKI has a worse Quick ratio (1.87) than 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.87
PKI Yearly Current Assets VS Current LiabilitesPKI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • PKI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.47%.
  • Measured over the past years, PKI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.15% on average per year.
  • The Revenue has decreased by -3.37% in the past year.
  • Measured over the past years, PKI shows a small growth in Revenue. The Revenue has been growing by 7.97% on average per year.
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.04% on average over the next years.
  • PKI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.60% yearly.
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PKI Yearly Revenue VS EstimatesPKI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PKI Yearly EPS VS EstimatesPKI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.51, which indicates a correct valuation of PKI.
  • 96.83% of the companies in the same industry are more expensive than PKI, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.92, PKI is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 22.11, the valuation of PKI can be described as rather expensive.
  • 77.78% of the companies in the same industry are more expensive than PKI, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of PKI to the average of the S&P500 Index (27.78), we can say PKI is valued slightly cheaper.
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
PKI Price Earnings VS Forward Price EarningsPKI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PKI is valued cheaply inside the industry as 93.65% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PKI indicates a rather cheap valuation: PKI is cheaper than 87.30% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.52
EV/EBITDA 12.35
PKI Per share dataPKI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • PKI has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as PKI's earnings are expected to decrease with -4.57% in the coming years.
PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PKI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PERKINELMER INC

NYSE:PKI (5/15/2023, 8:04:00 PM)

After market: 115.24 0 (0%)

115.24

-1.06 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-11
Earnings (Next)07-31
Inst Owners86.56%
Inst Owner Change-1.53%
Ins Owners0.81%
Ins Owner Change0%
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Analysts73
Price Target159.39 (38.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP4.74%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.02%
Min EPS beat(2)2.33%
Max EPS beat(2)3.7%
EPS beat(4)4
Avg EPS beat(4)8.57%
Min EPS beat(4)2.33%
Max EPS beat(4)14.5%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.78%
Min Revenue beat(2)-30.42%
Max Revenue beat(2)-29.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-30.42%
Max Revenue beat(4)52.86%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.68%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.39%
Valuation
Industry RankSector Rank
PE 14.51
Fwd PE 22.11
P/S 3.19
P/FCF 24.52
P/OCF 21.43
P/B 1.97
P/tB N/A
EV/EBITDA 12.35
EPS(TTM)7.94
EY6.89%
EPS(NY)5.21
Fwd EY4.52%
FCF(TTM)4.7
FCFY4.08%
OCF(TTM)5.38
OCFY4.67%
SpS36.16
BVpS58.4
TBVpS-19.59
PEG (NY)N/A
PEG (5Y)0.66
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.11%
ROCE N/A
ROIC 6.49%
ROICexc 6.74%
ROICexgc 35.96%
OM 23.43%
PM (TTM) 16.32%
GM 58.39%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)8.57%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0.99%
ROICexgc growth 5Y-8%
ROICexc growth 3Y-3.25%
ROICexc growth 5Y0.67%
OM growth 3Y19.66%
OM growth 5Y11.6%
PM growth 3Y29.61%
PM growth 5Y5.8%
GM growth 3Y7.46%
GM growth 5Y4.78%
F-Score7
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 7.4
Debt/EBITDA 2.93
Cap/Depr 20.05%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 79.63%
Current Ratio 2.13
Quick Ratio 1.87
Altman-Z 2.51
F-Score7
WACC10.02%
ROIC/WACC0.65
Cap/Depr(3y)26.47%
Cap/Depr(5y)33.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)118.43%
Profit Quality(5y)114.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.47%
EPS 3Y24.65%
EPS 5Y22.15%
EPS Q2Q%-33.59%
EPS Next Y-34.36%
EPS Next 2Y-12.79%
EPS Next 3Y-4.57%
EPS Next 5Y6.04%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y4.72%
Revenue growth 5Y7.97%
Sales Q2Q%-27.89%
Revenue Next Year-31.32%
Revenue Next 2Y-15.11%
Revenue Next 3Y-8.6%
Revenue Next 5YN/A
EBIT growth 1Y-24.58%
EBIT growth 3Y25.31%
EBIT growth 5Y20.49%
EBIT Next Year-23.7%
EBIT Next 3Y-3.21%
EBIT Next 5Y3.97%
FCF growth 1Y-54.67%
FCF growth 3Y28.17%
FCF growth 5Y18.96%
OCF growth 1Y-51.81%
OCF growth 3Y23.2%
OCF growth 5Y18.7%

PERKINELMER INC / PKI FAQ

What is the ChartMill fundamental rating of PERKINELMER INC (PKI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PKI.


What is the valuation status of PERKINELMER INC (PKI) stock?

ChartMill assigns a valuation rating of 7 / 10 to PERKINELMER INC (PKI). This can be considered as Undervalued.


Can you provide the profitability details for PERKINELMER INC?

PERKINELMER INC (PKI) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for PKI stock?

The Earnings per Share (EPS) of PERKINELMER INC (PKI) is expected to decline by -34.36% in the next year.


Can you provide the dividend sustainability for PKI stock?

The dividend rating of PERKINELMER INC (PKI) is 0 / 10 and the dividend payout ratio is 4.74%.